-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
UroGen Pharma Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q2 2024.
- UroGen Pharma Ltd. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$14K, a 53.3% increase year-over-year.
- UroGen Pharma Ltd. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $686K.
- UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2023 was $838K, a 1064% increase from 2022.
- UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2022 was $72K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)